跳至主要内容
临床试验/ISRCTN77172005
ISRCTN77172005已完成未知

Effects of exercise and diet interventions on obesity-related sleep disorders: a randomized controlled trial in men

Finnish Funding Agency for Technology and Innovation (TEKES)0 个研究点目标入组 45 人开始时间: 2012年10月23日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
45

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • Current inclusion criteria as of 25/02/2013:
  • Apnea and insomnia patient groups:
  • 1. Men in an age range of 30 to 65 years
  • 2. Occasionally physically active or sedentary (regular leisure-time exercise = 2 times/wk & = 45 min/time)
  • 3. Reports recurrent difficulty in falling asleep, too short sleep duration or poor quality of sleep during past 2 months. Or with mild to moderate OSA (AHI 5-30 / hour), with or without continuous positive airway pressure (CPAP) treatment. If under treatment, nasal CPAP for a minimum period of 6 months prior the baseline measurements, with a minimum adherence to CPAP therapy for 4 hours per night
  • 4. Relatively healthy (free from cardiovascular comorbidities)
  • Reference (healthy men) group:
  • 1. Men in an age range of 30 to 65 years
  • 2. No chronic sleep disorders and medications related to sleep disorders
  • 3. No disease and medications during past 1 year
  • 4. Relatively healthy (free from cardiovascular comorbidities)
  • Previous inclusion criteria until 25/02/2013:
  • 1. Males with an age range of 30 to 65 years
  • 2. Occasionally physically active or sedentary (regular exercise = 2 times/wk& = 45 min/time)
  • 3. Reported recurrent difficulty in falling asleep, too short sleep time or poor quality of sleep during past 2 months, or diagnosed with Mild to moderate obstructive sleep apnea (AHI 5-30 / hour), with or without CPAP treatment. If under treatment, nasal CPAP for a minimum period of 6 months, with a minimum adherence to CPAP therapy for 4 hours per night.
  • 4. Relatively healthy (free from cardiovascular comorbidities)

排除标准

  • Current exclusion criteria as of 25/02/2013:
  • 1. Diseases and medications related to insulin dependent diabetes mellitus, Crohn?s disease, sarcoidosis, celiac disease, thyroid, liver and severe heart diseases, chronic diarrhea, ulcerative colitis, rheumatoid arthritis, severe osteoarthritis, systemic lupus erythematous, cancer during past 3 years.
  • 2. Currently taking special diet (such as very low calorie diet)
  • 3. Other diagnosed sleep disorders (such as narcolepsy)
  • 4. Shift workers (working during night)
  • 5. Reported cognitive impairment
  • 6. Using antibiotics during the previous 3 months
  • 7. History of eating disorders
  • 8. Subjects using CPAP, professional drivers and other professions that are at risk for accident due to discontinuation in CPAP treatment
  • 9. Not suitable for the study by a physician?s evaluation
  • Previous exclusion criteria until 25/02/2013:
  • 1. Diseases and medications related to insulin dependent diabetes mellitus, Crohn?s disease, sarcoidosis, celiac disease, thyroid, liver and severe heart diseases, chronic diarrhea, ulcerative colitis, rheumatoid arthritis, severe osteoarthritis, systemic lupus erythematous, cancer during past 3 years.
  • 2. Diet with very low calorie (VLCD)
  • 3. Other sleep disorders e.g. narcolepsy
  • 4. Shift workers (working during night)
  • 5. Reported cognitive impairment
  • 6. Using antibiotics during the previous 3 months
  • 7. History of eating disorders
  • 8. In patients under CPAP treatment, professional drivers and other professions that are at risk for accident due to discontinuation of CPAP treatment
  • 9. Not suitable for the study by a physician?s evaluation

研究者

发起方
Finnish Funding Agency for Technology and Innovation (TEKES)

相似试验

Monitoring and treatment of obesity-related sleep... | 临床试验